CNBC Halftime Report Final Trades: AstraZeneca, Leidos Holdings, Expeditors International of Washington, U.S. 10 Year Treasury

AZN's Etcamah Fails Late-Stage Study for First-line Breast Cancer

AstraZeneca announced that its phase III SERENA-4 study evaluating Etcamah combined with Pfizer's Ibrance failed to meet its primary endpoint of progression-free survival as first-line treatment for ER-positive, HER2-negative advanced breast cancer, though numerical improvement was observed. The failure does not affect Etcamah's recent FDA approval for a switch strategy in patients with ESR1 resistance mutations.

Lupus Nephritis Market on a Growth Trajectory at a CAGR of 7% During the Forecast Period (2026–2036), as Innovative Therapies Gain Momentum | DelveInsight

The lupus nephritis market is projected to grow at a 7% CAGR through 2036, driven by increasing disease awareness, improved diagnosis, and expanding adoption of targeted therapies. The market was valued at USD 2.1 billion in 2025 across seven major markets. Three therapies have received FDA approval (belimumab, voclosporin, and obinutuzumab), while a robust pipeline of innovative treatments including CAR-T therapies, complement inhibitors, and monoclonal antibodies is expected to transform disease management.

Cellectis Pivots to Gene Editing in Major Overhaul

Cellectis (NASDAQ: CLLS) pivots to in vivo gene editing, extending cash runway to H2 2028. Read pipeline updates on .HEAL-101 & .HEAL-201.

Old Dominion Unveils Solid LTL Unit Performance for August

Old Dominion Freight Line (ODFL) reported 12.4% year-over-year revenue per day growth in August 2026, driven by increased LTL revenue per hundredweight, despite a 0.9% decline in tons per day. Quarter-to-date LTL revenue per hundredweight rose 11.3% (4.8% excluding fuel surcharges). CEO Marty Freeman expressed confidence in the company's strategic positioning and capacity to capture profitable market share.

Department of Navy Awards Leidos $875M Contract Option To Secure And Maintain Critical Networks Worldwide

Leidos (NYSE:LDOS) will continue helping keep more than 650,000 U.S. Navy and Marine Corps personnel securely connected by managing more than 425,000 devices at more than 2,500 sites around the world.The Navy recently

Shares of services-related industrials companies are trading higher after AI executives from firms including Anthropic, OpenAI and SpaceXAI signaled that the industry's growth may have to be slowed, which may limit harmful competition for firms that rely on tech-heavy business segments.